Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medexus Pharmaceuticals Inc MEDXF


Primary Symbol: T.MDP

Medexus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a North American commercial platform. The Company has a portfolio of rare disease treatment solutions. The Company is focused on the therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy and dermatology. The Company has two divisions: Medexus Pharma Canada and Medexus Pharma USA... see more

TSX:MDP - Post Discussion

Medexus Pharmaceuticals Inc > Prediction Alert!
View:
Post by Rockafellow2 on Oct 05, 2023 4:20pm

Prediction Alert!

This will shoot up $7 bucks the day they announce debt reduction on Oct 16th ... not before.
That's a week this coming Monday ...
Get ready to fill your pockets.
Imo
Comment by Napcoo on Oct 06, 2023 8:02am
Debt reduction?! 40 mln debentures due on October 16, the company issued new debt to replace old debt or issue new shares by diluting, the fundamental did not change, still heavy in debt
Comment by zakmirza on Nov 02, 2023 11:26am
Yup.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities